Pluristem Therapeutics Inc.
Overview
Pluristem Therapeutics Inc. is a biotechnology company that specializes in the development of placenta-based cell therapy products. The company's proprietary technology platform focuses on producing highly potent allogeneic cell products for the treatment of numerous high-impact indications.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Pluristem Therapeutics Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.
Is this Pluristem Therapeutics Inc.? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.